Promino Nutritional Sciences Inc.
MUSL
CNSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 180.70K | 240.60K | 320.00K | 355.10K | 198.60K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 180.70K | 240.60K | 320.00K | 355.10K | 198.60K |
| Cost of Revenue | 726.20K | 1.35M | 1.37M | 1.39M | 2.14M |
| Gross Profit | -545.40K | -1.11M | -1.05M | -1.03M | -1.94M |
| SG&A Expenses | 8.34M | 6.26M | 4.77M | 3.15M | 2.70M |
| Depreciation & Amortization | 5.40K | 10.80K | 16.20K | 21.60K | 23.40K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.13M | 7.63M | 6.16M | 4.56M | 4.87M |
| Operating Income | -8.95M | -7.39M | -5.84M | -4.21M | -4.67M |
| Income Before Tax | -8.52M | -7.03M | -5.82M | -4.28M | -4.95M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -8.52 | -7.03 | -5.82 | -4.28 | -4.95 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.52M | -7.03M | -5.82M | -4.28M | -4.95M |
| EBIT | -8.95M | -7.39M | -5.84M | -4.21M | -4.67M |
| EBITDA | -8.93M | -7.37M | -5.82M | -4.19M | -4.65M |
| EPS Basic | -0.16 | -0.15 | -0.14 | -0.11 | -0.12 |
| Normalized Basic EPS | -0.11 | -0.10 | -0.09 | -0.08 | -0.08 |
| EPS Diluted | -0.16 | -0.15 | -0.14 | -0.11 | -0.12 |
| Normalized Diluted EPS | -0.11 | -0.10 | -0.09 | -0.08 | -0.08 |
| Average Basic Shares Outstanding | 257.62M | 272.54M | 245.48M | 225.08M | 229.83M |
| Average Diluted Shares Outstanding | 257.62M | 272.54M | 245.48M | 225.08M | 229.83M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
